Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-07

Clinical Trial Update: CorPath™ 200: Robotically-Assisted Percutaneous Coronary Intervention (PCI) [Phase 2]

View source ↗

Summary

Phase 2 results update on the CorPath 200 robotic system for performing percutaneous coronary interventions in coronary artery disease patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CorPath 200

Snippet

Sponsor: Corindus Inc. | Conditions: Coronary Artery Disease | Phase 2 | Status: COMPLETED | Results posted: 2015-09-07